Home/Filings/4/0001562180-21-007532
4//SEC Filing

Hinton Bryan Richard 4

Accession 0001562180-21-007532

CIK 0001636422other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 4:14 PM ET

Size

15.2 KB

Accession

0001562180-21-007532

Insider Transaction Report

Form 4
Period: 2021-12-02
Hinton Bryan Richard
Chief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-12-03$10.78/sh+105$1,13215,937 total
  • Sale

    Common Stock

    2021-12-03$42.87/sh105$4,50115,832 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-12-03$10.78/sh105$1,132529 total
    Exercise: $10.78Exp: 2028-05-03Common Stock (105 underlying)
  • Tax Payment

    Common Stock

    2021-12-02$41.95/sh2,918$122,40315,832 total
  • Sale

    Common Stock

    2021-12-06$37.69/sh1,400$52,77214,432 total
  • Sale

    Common Stock

    2021-12-06$38.64/sh5,057$195,3969,375 total
Footnotes (6)
  • [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  • [F2]Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.
  • [F3]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.
  • [F4]Represents the weighted average sale price of the shares sold ranging from $37.35 to $38.21 per share, inclusive.
  • [F5]Represents the weighted average sale price of the shares sold ranging from $38.37 to $39.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (5).
  • [F6]25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022.

Issuer

Health Catalyst, Inc.

CIK 0001636422

Entity typeother

Related Parties

1
  • filerCIK 0001855244

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:14 PM ET
Size
15.2 KB